Narrative Update • May 23
Have your own idea? Try our Stock Screener
Spanish (IBEX) Healthcare Sector Analysis
UpdatedMay 29, 2026
DataAggregated Company Financials
Companies13
- 7D1.5%
- 3M-10.0%
- 1Y8.9%
- YTD-5.7%
In the last week, the Healthcare industry is up 1.5%, with Almirall leading the way, up 3.2%. This takes the industry's 12 month performance to a gain of 8.9%. Earnings are forecast to grow by 24% annually.
Sector Valuation and Performance
Has the Spanish Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 29 May 2026 | €16.6b | €11.3b | €750.0m | 22.6x | 22.1x | 1.5x |
| Sun, 26 Apr 2026 | €17.4b | €11.4b | €747.8m | 21.9x | 23.3x | 1.5x |
| Tue, 24 Mar 2026 | €16.5b | €11.4b | €776.9m | 20.3x | 21.3x | 1.4x |
| Thu, 19 Feb 2026 | €18.8b | €11.3b | €706.2m | 33.2x | 26.6x | 1.7x |
| Sat, 17 Jan 2026 | €17.9b | €11.3b | €706.2m | 30.5x | 25.4x | 1.6x |
| Mon, 15 Dec 2025 | €17.2b | €11.3b | €700.9m | 26.3x | 24.5x | 1.5x |
| Wed, 12 Nov 2025 | €16.3b | €11.2b | €678.7m | 25x | 24x | 1.5x |
| Fri, 10 Oct 2025 | €17.4b | €11.1b | €621.8m | 25.1x | 28x | 1.6x |
| Sun, 07 Sep 2025 | €17.5b | €11.1b | €610.7m | 25.7x | 28.6x | 1.6x |
| Tue, 05 Aug 2025 | €17.3b | €11.1b | €610.7m | 25.2x | 28.3x | 1.6x |
| Thu, 03 Jul 2025 | €16.0b | €11.0b | €507.5m | 21.4x | 31.6x | 1.5x |
| Sat, 31 May 2025 | €15.5b | €10.9b | €506.9m | 21.7x | 30.5x | 1.4x |
| Mon, 28 Apr 2025 | €13.9b | €10.8b | €452.0m | 20.7x | 30.8x | 1.3x |
| Wed, 26 Mar 2025 | €14.6b | €10.8b | €458.8m | 19.8x | 31.9x | 1.4x |
| Fri, 21 Feb 2025 | €14.9b | €10.6b | €392.5m | 16.9x | 38x | 1.4x |
| Sun, 19 Jan 2025 | €14.3b | €10.6b | €392.4m | 18.7x | 36.3x | 1.4x |
| Tue, 17 Dec 2024 | €14.8b | €10.6b | €392.5m | 19.5x | 37.7x | 1.4x |
| Thu, 14 Nov 2024 | €15.9b | €10.5b | €394.5m | 20.3x | 40.3x | 1.5x |
| Sat, 12 Oct 2024 | €15.3b | €10.2b | €394.8m | 15.3x | 38.7x | 1.5x |
| Mon, 09 Sep 2024 | €15.0b | €10.2b | €399.9m | 14.6x | 37.4x | 1.5x |
| Wed, 07 Aug 2024 | €14.2b | €10.2b | €396.0m | 14.6x | 35.9x | 1.4x |
| Fri, 05 Jul 2024 | €14.6b | €10.0b | €405.9m | 19.2x | 36x | 1.5x |
| Sun, 02 Jun 2024 | €15.5b | €10.0b | €396.3m | 20.1x | 39.1x | 1.5x |
| Tue, 30 Apr 2024 | €14.0b | €10.0b | €297.7m | 17.5x | 47x | 1.4x |
| Thu, 28 Mar 2024 | €13.7b | €10.0b | €289.0m | 20.8x | 47.3x | 1.4x |
| Sat, 24 Feb 2024 | €15.2b | €10.0b | €286.4m | 17.8x | 53.1x | 1.5x |
| Mon, 22 Jan 2024 | €13.2b | €10.0b | €332.5m | 17.4x | 39.6x | 1.3x |
| Wed, 20 Dec 2023 | €16.5b | €10.0b | €332.6m | 17.2x | 49.5x | 1.7x |
| Fri, 17 Nov 2023 | €14.9b | €9.9b | €340.5m | 17.3x | 43.8x | 1.5x |
| Sun, 15 Oct 2023 | €14.6b | €9.8b | €302.1m | 18.4x | 48.4x | 1.5x |
| Tue, 12 Sep 2023 | €15.2b | €9.8b | €311.0m | 19.2x | 49x | 1.6x |
| Thu, 10 Aug 2023 | €15.3b | €9.8b | €311.0m | 21.5x | 49.1x | 1.6x |
| Sat, 08 Jul 2023 | €13.7b | €9.6b | €364.6m | 18.9x | 37.5x | 1.4x |
| Mon, 05 Jun 2023 | €13.7b | €9.6b | €366.5m | 21.2x | 37.3x | 1.4x |
Price to Earnings Ratio
37.3x
Current Industry PE
- Investors are pessimistic on the Spanish Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 22.1x which is lower than its 3-year average PE of 36.0x.
- The industry is trading close to its 3-year average PS ratio of 1.5x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 27% per year over the last three years.
- Revenues for these companies have grown 5.8% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Spanish Healthcare sector?
| ES Market | 1.20% | |
| Healthcare | 1.52% | |
| Healthcare Services | 6.93% | |
| Pharma | 1.69% | |
| Biotech | 0.76% | |
| Medical Equipment | -2.62% | |
| Life Sciences | -5.49% | |
Industry PE
- Investors are most optimistic about the Pharma industry, which is trading close to its 3-year average PE ratio of 27.1x.
- Analysts are expecting annual earnings growth of 20.3%, which is higher than its past year's earnings decline of 15.4% per year.
Forecasted Growth
- Analysts are most optimistic on the Life Sciences industry, expecting annual earnings growth of 121% over the next 5 years.
- In contrast, the Pharma industry is expected to see its earnings grow by 20% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| CBAV Clínica Baviera | €58.00 | 7.8% +€67.3m | 48.3% | PE22.1x | |
| ROVI Laboratorios Farmaceuticos Rovi | €59.30 | 0.4% +€12.8m | 8.9% | PE23x | |
| ORY Oryzon Genomics | €3.14 | 3.8% +€9.0m | 16.4% | PS22.6x | |
| FAE Faes Farma | €4.66 | 0.5% +€7.8m | 6.6% | PE17.7x | |
| PRM Prim | €13.50 | 1.1% +€2.6m | 25.0% | PE13.8x |